by Baylor College of Medicine Samples of SARS-CoV-2 Mpro molecules tested in this work. Credit: The authors / PNAS, 2021 Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat...
